Incidence of Pneumocystis Jiroveci Pneumonia in Patients with ANCA Vasculitis Initiating Therapy with Rituximab or Cyclophosphamide

被引：0
|
作者：
Nettleton, Elizabeth [1 ]
Sattui, Sebastian [2 ]
Wallace, Zachary [3 ]
Putman, Mike [1 ]
机构：
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1081
引用
收藏
页码：2149 / 2152
页数：4
相关论文
共 50 条
  • [21] Does Pneumocystis Jiroveci Pneumonia (PJP) Prophylaxis Prevent Hospitalizations for Other Infections in Vasculitis Patients?
    Patel, Veena
    Trotter, Kim
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [22] Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis.
    Stone, John H.
    Merkel, Peter A.
    Spiera, Robert
    Seo, Philip
    Langford, Carol A.
    Hoffman, Gary S.
    Kallenberg, Cees G. M.
    Clair, E. William St.
    Turkiewicz, Anthony
    Tchao, Nadia K.
    Webber, Lisa
    Ding, Linna
    Sejismundo, Lourdes P.
    Mieras, Kathleen
    Weitzenkamp, David
    Ikle, David
    Seyfert-Margolis, Vicki
    Mueller, Mark
    Brunetta, Paul
    Allen, Nancy B.
    Fervenza, Fernando C.
    Geetha, Duvuru
    Keogh, Karina A.
    Kissin, Eugene Y.
    Monach, Paul A.
    Peikert, Tobias
    Stegeman, Coen
    Ytterberg, Steven R.
    Specks, Ulrich
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (03): : 221 - 232
  • [23] ANCA vasculitis—does addition of rituximab allow sparing of cyclophosphamide?
    Moog P.
    Der Nephrologe, 2018, 13 (5): : 350 - 351
  • [24] Rituximab, Cyclophosphamide, and Corticosteroids for ANCA Vasculitis: The Good, the Bad, and the Ugly
    Fenoglio, Roberta
    Roccatello, Dario
    Sciascia, Savino
    KIDNEY & BLOOD PRESSURE RESEARCH, 2020, 45 (06): : 784 - 791
  • [25] RITUXIMAB VS. COMBINATION OF RITUXIMAB AND CYCLOPHOSPHAMIDE INDUCTION THERAPY FOR ANCA-ASSOCIATED VASCULITIS: A RETROSPECTIVE STUDY
    Von Allwoerden, K.
    Klapa, S.
    Werth, S. C.
    Mueller, A.
    Riemekasten, G.
    Nitschke, M.
    Thaci, D.
    Lamprecht, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 912 - 913
  • [26] Incidence of Pneumocystis jiroveci Pneumonia among Groups at Risk in HIV-negative Patients
    Fillatre, Pierre
    Decaux, Olivier
    Jouneau, Stephane
    Revest, Matthieu
    Gacouin, Arnaud
    Robert-Gangneux, Florence
    Fresnel, Annie
    Guiguen, Claude
    Le Tulzo, Yves
    Jego, Patrick
    Tattevin, Pierre
    AMERICAN JOURNAL OF MEDICINE, 2014, 127 (12): : 1242.e11 - 1242.e17
  • [27] Pneumocystis jiroveci pneumonia in patients receiving dasatinib treatment
    Chang, Hung
    Hung, Yu-Shin
    Chou, Wen-Chi
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 25 : 165 - 167
  • [28] Clinical picture of Pneumocystis jiroveci pneumonia in cancer patients
    Bollee, Guillaume
    Sarfati, Claudine
    Thiery, Guillaume
    Bergeron, Anne
    de Miranda, Sandra
    Menotti, Jean
    de Castro, Nathalie
    Tazi, Abdellatif
    Schlemmer, Benoit
    Azoulay, Elie
    CHEST, 2007, 132 (04) : 1305 - 1310
  • [29] Molecular diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients
    Jarboui, M. A.
    Sellami, A.
    Sellami, H.
    Cheikhrouhou, F.
    Makni, F.
    Ben Arab, N.
    Ben Jemaa, M.
    Ayadi, A.
    MYCOSES, 2010, 53 (04) : 329 - 333
  • [30] Pneumocystis jiroveci Pneumonia in Patients with Non-Hodgkin's Lymphoma Receiving Chemotherapy Containing Rituximab
    Chang, Hung
    Yeh, Huei-Chung
    Su, Yung-Cheng
    Lee, Ming-Hsun
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2008, 71 (11) : 579 - 582
12345